Fukagawa M - Search Results

1

An acute phase protein α₁-acid glycoprotein mitigates AKI and its progression to CKD through its anti-inflammatory action.

Watanabe H, Fujimura R, Hiramoto Y, Murata R, Nishida K, Bi J, Imafuku T, Komori H, Maeda H, Mukunoki A, Takeo T, Nakagata N, Tanaka M, Matsushita K, Fukagawa M, Maruyama T. Watanabe H, et al. Among authors: fukagawa m. Sci Rep. 2021 Apr 12;11(1):7953. doi: 10.1038/s41598-021-87217-8. Sci Rep. 2021. PMID: 33846468 Free PMC article.

2

Efficacy of percutaneous ethanol injection therapy for secondary hyperparathyroidism in patients on hemodialysis as evaluated by parathyroid hormone levels according to K/DOQI guidelines.

Tanaka M, Itoh K, Matsushita K, Matsushita K, Fukagawa M. Tanaka M, et al. Among authors: fukagawa m. Ther Apher Dial. 2005 Feb;9(1):48-52. doi: 10.1111/j.1774-9987.2005.00214.x. Ther Apher Dial. 2005. PMID: 15828906

3

Combination therapy of intravenous maxacalcitol and percutaneous ethanol injection therapy lowers serum parathyroid hormone level and calcium x phosphorus product in secondary hyperparathyroidism.

Tanaka M, Itoh K, Matsushita K, Matsushita K, Fukagawa M. Tanaka M, et al. Among authors: fukagawa m. Nephron Clin Pract. 2006;102(1):c1-7. doi: 10.1159/000088163. Epub 2005 Sep 13. Nephron Clin Pract. 2006. PMID: 16166800

4

[Bone and bone related biochemical examinations. Hormone and hormone related substances. Parathyroid hormone].

Tanaka M, Fukagawa M. Tanaka M, et al. Among authors: fukagawa m. Clin Calcium. 2006 Jun;16(6):927-34. Clin Calcium. 2006. PMID: 16751687 Review. Japanese.

5

The kidney and bone metabolism: Nephrologists' point of view.

Fukagawa M, Hamada Y, Nakanishi S, Tanaka M. Fukagawa M, et al. J Bone Miner Metab. 2006;24(6):434-8. doi: 10.1007/s00774-006-0719-7. J Bone Miner Metab. 2006. PMID: 17072734 Review.

6

[Basic and clinical aspects of calcimimetics. Treatment of secondary hyperparathyroidism in dialysis patients with calcimimetics].

Tanaka M, Fukagawa M. Tanaka M, et al. Among authors: fukagawa m. Clin Calcium. 2008 Jan;18(1):89-93. Clin Calcium. 2008. PMID: 18175877 Review. Japanese.

7

Serum pro-hepcidin as an indicator of iron status in dialysis patients.

Tsuchihashi D, Abe T, Komaba H, Fujii H, Hamada Y, Nii-Kono T, Tanaka M, Fukagawa M. Tsuchihashi D, et al. Among authors: fukagawa m. Ther Apher Dial. 2008 Jun;12(3):226-31. doi: 10.1111/j.1744-9987.2008.00578.x. Ther Apher Dial. 2008. PMID: 18503700

8

Treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).

Komaba H, Tanaka M, Fukagawa M. Komaba H, et al. Among authors: fukagawa m. Intern Med. 2008;47(11):989-94. doi: 10.2169/internalmedicine.47.1051. Epub 2008 Jun 2. Intern Med. 2008. PMID: 18520108 Free article. Review.

9

Putative role of endothelial lipase in dialysis patients with hypoalbuminemia and inflammation.

Fujii H, Fukuda A, Tanaka M, Kojima Y, Ishida T, Hirata K, Fukagawa M. Fujii H, et al. Among authors: fukagawa m. Am J Nephrol. 2008;28(6):974-81. doi: 10.1159/000144025. Epub 2008 Jul 9. Am J Nephrol. 2008. PMID: 18612200

10

Cinacalcet effectively reduces parathyroid hormone secretion and gland volume regardless of pretreatment gland size in patients with secondary hyperparathyroidism.

Komaba H, Nakanishi S, Fujimori A, Tanaka M, Shin J, Shibuya K, Nishioka M, Hasegawa H, Kurosawa T, Fukagawa M. Komaba H, et al. Among authors: fukagawa m. Clin J Am Soc Nephrol. 2010 Dec;5(12):2305-14. doi: 10.2215/CJN.02110310. Epub 2010 Aug 26. Clin J Am Soc Nephrol. 2010. PMID: 20798251 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

614 results

Search Page